|
業務類別
|
-- |
|
業務概覽
|
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. |
| 公司地址
| 3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634 |
| 電話號碼
| +1 216 431-9900 |
| 傳真號碼
| +1 216 361-9495 |
| 公司網頁
| https://www.athersys.com |
| 員工數量
| 24 |
| Ms. Maia A. Hansen |
Chief Operating Officer |
-- |
03/04/2023 |
| Mr. Daniel A. Camardo, M.B.A. |
Chief Executive Officer and Director |
-- |
17/08/2023 |
| Ms. Kasey Rosado |
Interim Chief Financial Officer and Principal Accounting Officer |
-- |
03/04/2023 |
|
|
| Mr. Jack L. Wyszomierski, M.S. |
Independent Director |
17/08/2023 |
| Ms. Jane Wasman, J.D. |
Chairman of the Board |
17/08/2023 |
| Mr. Daniel A. Camardo, M.B.A. |
Chief Executive Officer and Director |
17/08/2023 |
| Mr. Joseph Nolan |
Director |
05/01/2023 |
| Ms. Neema Mayhugh |
Director |
11/08/2023 |
|
|
|
|